Related Experiment Video
Updated: Jun 10, 2025

08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
17.6K
The p53/miRNA Axis in Breast Cancer
Reza Shah Hosseini1, Seyed Mohammad Nouri2, Pooja Bansal3,4
1Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkey.
DNA and Cell Biology
|October 18, 2024
Summary
The p53/microRNA (miRNA) axis is crucial in breast cancer (BC) development. Understanding this interaction may lead to new BC therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer (BC) is a prevalent global health concern.
- Genetic and environmental factors contribute to BC development.
- The p53 gene, a key tumor suppressor, interacts with microRNAs (miRNAs) in cancer pathways.
Purpose of the Study:
- To explore the regulatory relationship between the p53 gene and miRNAs in breast cancer.
- To elucidate the role of the p53/miRNA axis in BC progression and prevention.
- To identify potential therapeutic targets for BC treatment.
Main Methods:
- Literature review of studies on p53, miRNAs, and breast cancer.
- Analysis of molecular mechanisms underlying p53-miRNA interactions.
- Examination of signaling pathways affected by p53 and miRNA dysregulation.
Main Results:
- Mutations or degradation of p53 disrupt miRNA expression, increasing BC risk.
- Dysregulated miRNAs can negatively regulate p53, impacting cancer development.
- The p53/miRNA axis plays a critical role in BC pathogenesis.
Conclusions:
- The p53/miRNA axis is a vital pathway in breast cancer.
- Targeting this axis offers potential for novel BC therapeutic strategies.
- Further research into p53-miRNA interactions is warranted for clinical applications.
Related Concept Videos
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K

